Brittany C. Thomas

Illumina (United States) — United States

Medicine · Health Sciences

19h-index1.7kcitations70works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Genetic factors in colorectal cancer(15), Genomics and Rare Diseases(14), Cancer Genomics and Diagnostics(13), BRCA gene mutations in cancer(10), Genomic variations and chromosomal abnormalities(9)

Publications70 total

Evaluating the association between family cancer history and variants of uncertain significance
Gynecologic Oncology Reports·2025Open Access
P707: Systematic reanalysis of clinical genome sequencing data in a cohort of acute care patients
Genetics in Medicine Open·2025Open Access
P777: Genome sequencing detects transposable element (TE) insertions in two diagnostic challenging cases
Genetics in Medicine Open·2025Open Access
P412: An atypical case of pseudohypoparathyroidism 1b due to uniparental hetero- and isodisomy detected by genome sequencing
Genetics in Medicine Open·2025Open Access
Clinical genome sequencing in patients with suspected rare genetic disease in Peru
npj Genomic Medicine·2024· 4 citedOpen Access
Diagnostic yield of exome and genome sequencing after non-diagnostic multi-gene panels in patients with single-system diseases
Orphanet Journal of Rare Diseases·2024· 7 citedOpen Access
Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
Journal of Translational Medicine·2024Open Access
Executive Function as a Predictor of Pain Perception in Healthy Young Adults
Archives of Clinical Neuropsychology·2024· 1 cited
Development of a flipped learning course to deliver and scale molecular variant evaluation education: A quality improvement initiative
Journal of Genetic Counseling·2024· 1 cited
Table of Contents
Genetics in Medicine·2023Open Access
The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change
Genetics in Medicine·2023· 113 citedOpen Access
Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)
Journal of Translational Medicine·2023· 9 citedOpen Access
Supplementary Table 2 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Supplementary Figure 1 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Supplementary Table 1 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Supplementary Figure 1 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Supplementary Table 2 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Supplementary Table 1 from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Data from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
Data from Origins and Prevalence of the American Founder Mutation of <i>MSH2</i>
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Ryan J. Taft(7), Stephen N. Thibodeau(7), Jennifer L. Kemppainen(7), Denise Perry(6), Douglas L. Riegert‐Johnson(5), Noralane M. Lindor(5), Teresa Kruisselbrink(5), Kandelaria M. Rumilla(4), Erin Thorpe(4), Eric W. Klee(4), Filippo Pinto e Vairo(4), Samin A. Sajan(4), Maegan E. Roberts(3), Heidi L. Rehm(3), Vaidehi Jobanputra(3), McKinsey L. Goodenberger(3), Albert de la Chapelle(3), Heather Hampel(3), Jessica R. Balcom(3), Carolyn R. Rohrer Vitek(3)